XML 63 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Financial Instruments and Fair Value Disclosures (Tables)
12 Months Ended
Mar. 31, 2024
Financial Instruments and Fair Value Disclosures:  
Schedule of interest rate swaps, principal terms

    

    

 

 

Transaction

Termination

Fixed

Nominal value

 

Nominal value

 

Interest rate swap

Date

Date

interest rate

March 31, 2024

 

March 31, 2023

 

2023 A&R Debt Facility - ING(1)

September 2015

March 2025

0.9150

%  

28,649,740

36,695,201

2023 A&R Debt Facility - CACIB(2)

August 2022

March 2025

0.9208

%  

57,299,480

73,390,402

2023 A&R Debt Facility - BNP(3)

August 2022

March 2025

 

0.9208

%  

57,299,480

73,390,402

2023 A&R Debt Facility - ING(4)

January 2023

July 2029

 

2.8250

%  

20,751,300

$

164,000,000

$

183,476,005

(1)Reduces quarterly with a final settlement of $23.8 million in March 2025.
(2)Reduces quarterly with a final settlement of $47.6 million in March 2025.
(3)Reduces quarterly with a final settlement of $47.6 million in March 2025.
(4)Notional value increases to a high of $148.0 million on March 26, 2025 while other swaps amortize and then decreases with the debt outstanding under the 2023 A&R Debt Facility until final settlement of $80 million in July 2029.
Schedule of derivative instruments location on the statement of financial position

March 31, 2024

March 31, 2023

Current assets

Current liabilities

Current assets

Current liabilities

Derivatives not designated as hedging instruments

    

Derivative instruments

    

Derivative instruments

    

Derivative instruments

    

Derivative instruments

Interest rate swap agreements

$

5,139,056

$

$

$

March 31, 2024

March 31, 2023

 

Other non-current assets

Long-term liabilities

Other non-current assets

Long-term liabilities

 

Derivatives not designated as hedging instruments

    

Derivative instruments

    

Derivative instruments

    

Derivative instruments

    

Derivative instruments

 

Interest rate swap agreements

$

4,145,153

$

$

9,278,544

$

Schedule of derivative instruments effect within the unaudited interim consolidated statement of operations

Year ended

    

March 31, 2024

    

March 31, 2023

March 31, 2022

Unrealized gain/(loss) on investment securities

$

1,483,522

$

1,443,683

$

(1,587,090)

Realized gain on investment securities

 

872,557

987,206

447,255

Net gain/(loss) on investment securities

 

$

2,356,079

$

2,430,889

$

(1,139,835)

Schedule of derivative instruments summary of gains and losses on investment securities

Year ended

Derivatives not designated as hedging instruments

    

Location of gain/(loss) recognized

    

March 31, 2024

    

March 31, 2023

March 31, 2022

 

Interest rate swaps—change in fair value

 

Unrealized gain on derivatives

 

5,665

2,766,065

11,067,870

Interest rate swaps—realized gain/(loss)

 

Realized gain/(loss) on derivatives

 

7,493,246

3,771,522

(3,450,443)

Gain/(Loss) on derivatives, net

 

$

7,498,911

$

6,537,587

$

7,617,427

Schedule of carrying values and estimated fair values of fixed rate debt obligations

March 31, 2024

March 31, 2023

    

Carrying Value

    

Fair Value

    

Carrying Value

    

Fair Value

Corsair Japanese Financing

$

31,145,834

$

29,624,330

$

34,395,834

$

33,051,190

Cresques Japanese Financing

25,608,991

26,180,173

27,377,615

27,377,615

Cratis Japanese Financing

41,500,000

38,302,845

45,580,000

42,185,289

Copernicus Japanese Financing

41,500,000

38,302,845

45,580,000

42,185,289

Chaparral Japanese Financing

59,896,473

57,627,652

62,342,859

60,701,217

Caravelle Japanese Financing

42,500,000

39,003,038

46,100,000

42,707,169

Cougar Japanese Financing

43,700,000

43,715,910

47,300,000

47,300,000

Captain Markos Dual-Fuel Japanese Financing

53,270,000

54,923,798

55,790,000

55,790,000

BALCAP Facility

66,330,459

62,186,682

74,096,125

69,032,167